Jb lab - Company finances
|
EUR
|
2023
From: 2023-02-21
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 15,301 | 96,798 | 154,463 |
| Profit before tax | 3,532 | 7,309 | 533 |
| Net profit | 3,532 | 6,936 | 501 |
| Equity | 3,632 | 10,568 | 169 |
| Liabilities | 663 | 1,427 | 2,036 |
| Non-current assets | 0 | 2,641 | 1,725 |
| Current assets | 4,295 | 9,354 | 480 |
| Total assets | 4,295 | 11,995 | 2,205 |
|
Taxes paid
|
|||
| STI taxes | 401 | - | 373 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +532.6% | +59.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 82.2% | 57.8% | 22.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 97.2% | 65.6% | 296.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 23.1% | 7.2% | 0.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 23.1% | 7.6% | 0.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 12.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Jb lab - Social security debts
The amount of overdue SODRA debt for the company Jb lab as of the last working day is: 64 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 64.24 |
| 2026-09-01 | 2026-09-02 | 64.24 |
| 2026-02-03 | 2026-02-28 | 8.03 |
| 2025-03-03 | 2025-03-31 | 7.95 |
| 2025-03-01 | 2025-03-02 | 80.40 |
| 2025-02-01 | 2025-02-28 | 7.95 |
| 2024-11-04 | 2024-11-30 | 64.50 |
| 2024-07-02 | 2024-07-31 | 58.63 |
| 2024-06-03 | 2024-06-30 | 58.63 |
| 2024-05-03 | 2024-05-31 | 58.63 |
| 2024-05-02 | 2024-05-02 | 123.13 |
| 2024-04-03 | 2024-05-01 | 58.63 |
| 2024-03-01 | 2024-03-31 | 70.37 |
| 2024-02-01 | 2024-02-29 | 5.87 |
| 2024-01-03 | 2024-01-31 | 58.63 |
Jb lab - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Jb lab, MB (code 306251044) is a Small partnership engaged in the manufacture of prosthetic appliances, implants and orthodontic devices. In 2025, the company generated revenue of €154.5K, up 59.6% year on year and well above the €96.8K recorded in 2024 and €15.3K in 2023, showing a strong three-year expansion in sales. However, profitability weakened sharply in 2025: net profit was €501, compared with €6.9K in 2024 and €3.5K in 2023, and the net margin fell to 0.3% from 7.2% and 23.1% in the prior years. The balance sheet remained very small, with total assets of €2.2K, equity of €169 and liabilities of €2.0K at the end of 2025. The company’s equity ratio was 7.7% and debt-to-equity stood at 12.05, indicating heavy leverage relative to its narrow capital base. ROE and asset turnover were elevated, but these figures are strongly influenced by the very small equity and asset base in 2025.